Like other virtual health technologies, remote patient monitoring grew in the midst of the COVID-19 pandemic.
One study published in JAMA Internal Medicine earlier this month found a steep incline in its use among traditional Medicare beneficiaries, increasing from 91 claims per 100,000 enrollees in February 2020 to 594 claims per 100,000 enrollees in September 2021.
Waqaas Al-Siddiq, CEO of...
The end of an error. The Wall Street Journal reports that Theranos, the once-promising blood testing startup now plagued by scandals and lawsuits, will soon be shutting its doors for good. In a letter to shareholders obtained by the Journal, CEO and General Counsel David Taylor wrote that the company’s attempts to negotiate a sale transaction did not bear fruit, and that the company is in default...
Redwood City, California-based biotricity, which is working on a biometric remote monitoring solution, has received FDA clearance for the software component of their product.
The company’s first offering, which is slated for market launch later this year or early next year, is bioflux – a remote cardiac monitoring solution that includes a wearable heart monitor (to be worn on the torso) that uses...
Beginning this fall, Aetna will combine Apple’s consumer tech offerings with its analytics-based wellness and care management programs by integrating several iOS-exclusive health initiatives. First off, the company will make the Apple Watch available to some of its large employers and individual members during open enrollment season, and will be subsidizing part of the cost. Aetna will also be...
Dr. Mehmet Oz, a well-known television personality, has joined health technology startup iBeat as Special Advisor, in addition to making an investment in the company. The company makes a not-yet-launched smartwatch that offers continuous monitoring and analysis of heart rate, working to instantly detect signs of oncoming cardiac arrest. Oz, after reportedly seeing the potential impact of the...
Here are all the digital health deals, partnerships, and customer wins that MobiHealthNews has tracked over the past two weeks.
UK-based pharmaceutical giant GlaxoSmithKline partnered with South San Francisco-based Verily to create Galvani Bioelectronics – a joint venture to develop implantable bioelectric medicines, a branch of medicine that works to fight diseases by targeting electrical...
Digital entrepreneur and former Health 2.0 staffer Jean Luc Neptune announced on Twitter that he'd be leaving his position as Accelerator Director at Blueprint Health at the end of the month. He said, however, he'd remain a partner in Blueprint Health LLC and its investment fund.
This one is, admittedly, a stretch for a list of "recent" digital health departures, but important: At the end of...
